Skip to main content
. 2021 Dec 10;19:312. doi: 10.1186/s12916-021-02183-2

Table 1.

Main characteristics of women included (hormone non-users only), overall and in discovery and validation sets

Overall (n = 2358) Discovery (n = 1572) Validation (n = 786)
Age at blood collection (years) 53.9 (8.5) 53.1 (8.6) 55.5 (8.1)
Fasting status at blood collectiona (%)
 No 936 (39.7) 639 (40.6) 297 (37.8)
 In between 375 (15.9) 252 (16.0) 123 (15.6)
 Yes 1047 (44.4) 681 (43.3) 366 (46.6)
Menopausal status at blood collection (%)
 Premenopausal 722 (30.6) 522 (33.2) 200 (25.4)
 Postmenopausal 1294 (54.9) 808 (51.4) 486 (61.8)
 Perimenopausal 342 (14.5) 242 (15.4) 100 (12.7)
Age at first menstrual periods (years) (mean (SD)) 13.1 (1.6) 13.1 (1.6) 13.1 (1.6)
Number of full-term pregnancies (mean (SD)) 2.1 (1.3) 2.0 (1.2) 2.1 (1.4)
Age at first full-term pregnancy (years) (mean (SD)) 25.2 (4.3) 25.1 (4.4) 25.4 (4.2)
Breastfeeding (in parous women) (%)
 Yes 1669 (80.9) 1110 (80.7) 559 (81.2)
 No 280 (13.6) 181 (13.2) 99 (14.4)
 Missing 115 (5.6) 85 (6.2) 30 (4.4)
Ever used oral contraceptive (%) 1120 (47.5) 790 (50.3) 330 (42.0)
Ever used MHT (%) 297 (12.6) 198 (12.6) 99 (12.6)
Education level (%)
 Primary/no schooling 1162 (49.3) 743 (47.3) 419 (53.3)
 Technical/professional/secondary 819 (34.7) 560 (35.6) 259 (33.0)
 Longer education 377 (16.0) 269 (17.1) 108 (13.7)
Physical activity (Cambridge Index) (%)
 Inactive 623 (26.4) 388 (24.7) 235 (29.9)
 Moderately inactive 929 (39.4) 623 (39.6) 306 (38.9)
 Moderately active 450 (19.1) 307 (19.5) 143 (18.2)
 Active 356 (15.1) 254 (16.2) 102 (13.0)
Smoking status (%)
 Never 1406 (59.6) 934 (59.4) 472 (60.1)
 Former 480 (20.4) 299 (19.0) 181 (23.0)
 Smoker 472 (20.0) 339 (21.6) 133 (16.9)
Alcohol consumption at recruitment (%)
 Non-drinker 509 (21.6) 302 (19.2) 207 (26.3)
 > 0–3 g/day 707 (30.0) 482 (30.7) 225 (28.6)
 > 3–12 g/day 619 (26.3) 416 (26.5) 203 (25.8)
 > 12–24 g/day 337 (14.3) 239 (15.2) 98 (12.5)
 > 24 g/day 186 (7.9) 133 (8.5) 53 (6.7)
Height (cm) (mean (SD)) 160.4 (6.8) 160.6 (6.7) 160.0 (6.8)
BMI (kg/m2) (mean (SD)) 26.0 (4.3) 25.9 (4.3) 26.3 (4.4)
Waist circumference (cm) (mean (SD)) 81.9 (10.6) 81.5 (10.4) 82.6 (10.9)
Waist/hip ratio (mean (SD)) 0.80 (0.07) 0.80 (0.07) 0.81 (0.07)
Total energy intake (kcal/day) (mean (SD)) 2010.3 (547.7) 2016.3 (557.6) 1998.3 (527.4)
Healthy Lifestyle Indexb (mean(SD)) 12.6 (3.0) 12.6 (3.0) 12.8 (2.9)
WCRF/AICR scorec (mean (SD)) 3.9 (1.0) 3.9 (1.0) 3.9 (1.0)
Modified Mediterranean diet score (mean (SD)) 4.3 (1.8) 4.3 (1.8) 4.5 (1.7)
Inflammatory score of the diet (mean (SD)) 0.9 (1.7) 0.89 (1.7) 0.8 (1.7)
Diet Quality Index-International (mean (SD)) 57.4 (7.8) 57.2 (7.9) 57.8 (7.7)
Metabolite concentrations (normalized), μmol/L
 Arginine (geometric mean (SD)) 64.1 (2.6) 64.2 (2.6) 63.9 (2.6)
 Asparagine (geometric mean (SD)) 41.5 (2.7) 41.4 (2.7) 41.6 (2.7)
 C2 (geometric mean (SD)) 4.9 (2.7) 4.9 (2.7) 4.9 (2.6)
 PC aa C36:3 (geometric mean (SD)) 130.0 (2.6) 127.0 (2.6) 136.0 (2.7)
 PC ae C34:2 (geometric mean (SD)) 12.2 (2.7) 12.1 (2.8) 12.4 (2.7)
 PC ae C36:2 (geometric mean (SD)) 15.6 (2.7) 15.5 (2.7) 15.6 (2.7)
 PC ae C36:3 (geometric mean (SD)) 8.1 (2.7) 8.0 (2.7) 8.2 (2.7)
 PC ae C38:2 (geometric mean (SD)) 2.1 (2.7) 2.1 (2.7) 2.1 (2.8)

Abbreviations: AICR American Institute for Cancer Research, BMI body mass index, C2 acetylcarnitine, MHT menopause hormone therapy, PC aa phosphatidylcholine diacyl, PC ae phosphatidylcholine acyl-alkyl, SD standard deviation, WCRF World Cancer Research Fund

aNo: < 3 h since last meal (< 4 h in Umeå); in between: 3–6 h since last meal (4–8 h in Umeå); yes: > 6 h since last meal (> 8 h in Umeå)

bHealthy Lifestyle Index was missing for 144 (6.1%) participants

cWCRF/AICR score was missing for 196 (8.3%) participants